FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1573297152> ?p ?o ?g. }

• W1573297152 endingPage "462" @default.
• W1573297152 startingPage "462" @default.
• W1573297152 abstract "Article1 September 1960EVALUATION OF A CHOLESTEROL-SYNTHESIS INHIBITOR (TRIPARANOL)MICHAEL J. CARVER, Ph.D., JOHN G. FREEMAN, M.D., JACKSON A. SMITH, M.D., F.A.C.P.MICHAEL J. CARVER, Ph.D.Search for more papers by this author, JOHN G. FREEMAN, M.D.Search for more papers by this author, JACKSON A. SMITH, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-53-3-462 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe role of cholesterol in the etiology and pathogenesis of atherosclerosis is not clearly understood; nevertheless, an association between hypercholesterolemia and atherosclerosis most probably exists, and has prompted continual study of methods of decreasing the level of serum cholesterol.The findings of Blohm et al. that Triparanol§produced a cholesterol-lowering effect on rats, and that the effect was the result of an inhibition of cholesterol biosynthesis, were met with interest by investigators. It was further established by Blohm et al. that the inhibition noted was specific for cholesterol.2Avigan et al.1indicate that the principal site of action of Triparanol...Bibliography1. AviganSteinbergThompsonMosettig JDMJE: Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesis, Biochem. and Biophys. Research Communications 2: 63, 1960. CrossrefMedlineGoogle Scholar2. BlohmKariyaLaughlin TRTMW: Effects of MER-29, a cholesterol synthesis inhibitor, on mammalian tissue lipides, Arch. Biochem. and Biophys. 85: 250, 1959. CrossrefMedlineGoogle Scholar3. OaksLisan WP: A new cholesterol synthesis inhibitor, Federation Proc. 18: 428, 1959. Google Scholar4. OaksLisanMoyer WPJ: Inhibition of cholesterol synthesis with the use of MER-29, Arch. Int. Med. 104: 527, 1959. CrossrefMedlineGoogle Scholar5. RivinYoshinoShickmanSchjeide AUJMOA: Serum cholesterol measurement-hazards in clinical interpretation, J. A. M. A. 166: 2108, 1958. CrossrefMedlineGoogle Scholar6. WatkinLawryMannHalperin DMEYGVM: Study of serum beta lipoprotein and total cholesterol variability and its relation to age and serum level in adult human subjects, J. Clin. Investigation 33: 874, 1954. CrossrefMedlineGoogle Scholar7. ZakDickermanWhiteBurnettCherney BRCEGHPJ: Rapid estimation of free and total cholesterol, Am. J. Clin. Path. 24: 1307, 1954. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Received for publication May 13, 1960.†From the Nebraska Psychiatric Institute and the University of Nebraska College of Medicine, Omaha, Nebraska.‡Formerly of Nebraska Psychiatric Institute; now of Illinois State Psychiatric Institute, Chicago, Illinois.§1-[p-(β-diethylaminoethoxy)-phenyl]-1-(p-tolyl)-2-(p-chlorophenyl) ethanol. Triparanol used in this study was supplied as MER-29 by Wm. S. Merrell Company.This study was supported in part by the Nebraska Fund for Psychiatric Research and in part by a research grant (MY-2784) from National Institute of Mental Health, Public Health Service.Requests for reprints should be addressed to Michael J. Carver, M.D., Nebraska Psychiatric Institute, The University of Nebraska College of Medicine, 602 South Forty-fourth Avenue, Omaha 5, Nebraska. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHepatitis C Virus Selectively Alters the Intracellular Localization of DesmosterolApproaches to the Treatment of HypercholesteremiaSTANLEY S. BERGEN JR., M.D., THEODORE B. VAN ITALLIE, M.D., F.A.C.P.TRIPARANOL AND NICOTINIC ACID IN THE MANAGEMENT OF HYPERCHOLESTEROLAEMIAChemotherapeutic Approaches to the Problem of Hyperlipidemia 1 September 1960Volume 53, Issue 3Page: 462-467KeywordsAtherosclerosisBiosynthesisCholesterolEthanolEtiologyMedical servicesPathogenesisPsychiatry and mental healthResearch fundingResearch grants ePublished: 1 December 2008 Issue Published: 1 September 1960 PDF downloadLoading ..." @default.
• W1573297152 created "2016-06-24" @default.
• W1573297152 date "1960-09-01" @default.
• W1573297152 modified "2023-09-25" @default.
• W1573297152 title "EVALUATION OF A CHOLESTEROL-SYNTHESIS INHIBITOR (TRIPARANOL)" @default.
• W1573297152 cites W2029411101 @default.
• W1573297152 cites W2034937074 @default.
• W1573297152 cites W2055649727 @default.
• W1573297152 cites W2059106308 @default.
• W1573297152 cites W2071058307 @default.
• W1573297152 cites W2431905133 @default.
• W1573297152 doi "https://doi.org/10.7326/0003-4819-53-3-462" @default.
• W1573297152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13691207" @default.
• W1573297152 hasPublicationYear "1960" @default.
• W1573297152 type Work @default.
• W1573297152 sameAs 1573297152 @default.
• W1573297152 citedByCount "4" @default.
• W1573297152 countsByYear W15732971522016 @default.
• W1573297152 crossrefType "journal-article" @default.
• W1573297152 hasConcept C126322002 @default.
• W1573297152 hasConcept C134018914 @default.
• W1573297152 hasConcept C134651460 @default.
• W1573297152 hasConcept C181199279 @default.
• W1573297152 hasConcept C185592680 @default.
• W1573297152 hasConcept C202751555 @default.
• W1573297152 hasConcept C2776120743 @default.
• W1573297152 hasConcept C2778163477 @default.
• W1573297152 hasConcept C2780942790 @default.
• W1573297152 hasConcept C3017755632 @default.
• W1573297152 hasConcept C553450214 @default.
• W1573297152 hasConcept C55493867 @default.
• W1573297152 hasConcept C71924100 @default.
• W1573297152 hasConceptScore W1573297152C126322002 @default.
• W1573297152 hasConceptScore W1573297152C134018914 @default.
• W1573297152 hasConceptScore W1573297152C134651460 @default.
• W1573297152 hasConceptScore W1573297152C181199279 @default.
• W1573297152 hasConceptScore W1573297152C185592680 @default.
• W1573297152 hasConceptScore W1573297152C202751555 @default.
• W1573297152 hasConceptScore W1573297152C2776120743 @default.
• W1573297152 hasConceptScore W1573297152C2778163477 @default.
• W1573297152 hasConceptScore W1573297152C2780942790 @default.
• W1573297152 hasConceptScore W1573297152C3017755632 @default.
• W1573297152 hasConceptScore W1573297152C553450214 @default.
• W1573297152 hasConceptScore W1573297152C55493867 @default.
• W1573297152 hasConceptScore W1573297152C71924100 @default.
• W1573297152 hasIssue "3" @default.
• W1573297152 hasLocation W15732971521 @default.
• W1573297152 hasLocation W15732971522 @default.
• W1573297152 hasOpenAccess W1573297152 @default.
• W1573297152 hasPrimaryLocation W15732971521 @default.
• W1573297152 hasRelatedWork W1966834268 @default.
• W1573297152 hasRelatedWork W1972175381 @default.
• W1573297152 hasRelatedWork W1994826758 @default.
• W1573297152 hasRelatedWork W2005998106 @default.
• W1573297152 hasRelatedWork W2019813684 @default.
• W1573297152 hasRelatedWork W2032958076 @default.
• W1573297152 hasRelatedWork W2075372262 @default.
• W1573297152 hasRelatedWork W2142791464 @default.
• W1573297152 hasRelatedWork W2167322121 @default.
• W1573297152 hasRelatedWork W2168843442 @default.
• W1573297152 hasVolume "53" @default.
• W1573297152 isParatext "false" @default.
• W1573297152 isRetracted "false" @default.
• W1573297152 magId "1573297152" @default.
• W1573297152 workType "article" @default.